Chinese Journal of Pharmacovigilance ›› 2013, Vol. 10 ›› Issue (1): 44-45.

Previous Articles     Next Articles

Current Status on Safety Evaluation of Fluoroquinolones

LI Xing-ru, BI Feng-lan   

  1. 1.Huarun pharmaceutical group co., LTD, Beijing, 100091, China;
    2.Cener for Drug reevaluation, SFDA, Beijing 100045, China
  • Received:2012-08-26 Revised:2016-03-12 Online:2013-01-08 Published:2016-03-09

Abstract: Fluoroquinolones, as the forth generation of quinolones, are broadly used in clinical medicine because of various advantages, such as cheap price, well absorbed by oral, higher serum concentration, easy to use etc. In this paper, the author introduces the clinical development ,adverse drug reaction and current status on safety monitoring, discussing and analyzing the rational use, providing the reference for ensuring safety and efficacy of fluoroquinolones clinical application.

CLC Number: